166 Results for "

MDA-MB-468

" in MedChemExpress (MCE) Product Catalog:
Products (166)

166 Results for "MDA-MB-468" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-11038
CAS No.: 873436-91-0
Purity:  99.93%
Synonyms: PU-H71
Target:  

HSP

Research Areas:  

Cancer

Zelavespib (PU-H71) is a potent Hsp90 inhibitor, with an IC50 of 51 nM in MDA-MB-468 cells.
loading...
    loading...
13
13 Publications Verification
Cat. No.: HY-11038B
CAS No.: 2095432-24-7
Purity:  98.89%
Synonyms: PU-H71 hydrochloride
Target:  

HSP

Research Areas:  

Cancer

Zelavespib (PU-H71) hydrochloride is a potent Hsp90 inhibitor, with an IC50 of 51 nM in MDA-MB-468 cells.
loading...
    loading...
13
13 Publications Verification
Cat. No.: HY-11038D
Purity:  97.39%
Synonyms: PU-H71 formic
Target:  

HSP

Research Areas:  

Cancer

Zelavespib formic (PU-H71 formic) is a potent Hsp90 inhibitor with an IC50 value of 51 nM for Hsp90 in MDA-MB-468 cells .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-12807
CAS No.: 939055-18-2
Purity:  98.00%
Synonyms: 5-Fluoro-2-indolyl deschlorohalopemide
FIPI is a phospholipase D (PLD) inhibitor with an IC50 for PLD1 and PLD2 of about 25 nM. FIPI regulates cytoskeletal recombination, cell diffusion and chemotaxis. FIPI can be used in cancer research. In addition, FIPI can enhance the secretion and aggregation of platelet dense particles, inhibit thrombosis, reduce ischemic stroke infarct volume and improve nerve function .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N2959
CAS No.: 16503-32-5
Brevilin A is an orally active STAT3/JAK inhibitor (STAT3 IC50=?10.6 μM). Brevilin A shows anti-tumor activity, anti-proliferative activity to cancer cells, and can induce apoptosis and autophagy .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-139361
CAS No.: 2451481-08-4
Purity:  99.82%
Synonyms: PIN1-3
Target:  

PIN1

Research Areas:  

Cancer

Sulfopin (PIN1-3) is a highly selective covalent inhibitor of Pin1 with an apparent Ki of 17 nM. Sulfopin blocks Myc-driven tumors in vivo. The peptidyl-prolyl isomerase, Pin1, is exploited in cancer to activate oncogenes and inactivate tumor suppressors .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N0364
CAS No.: 55297-87-5
Falcarindiol, an orally active polyacetylenic oxylipin, activates PPARγ and increases the expression of the cholesterol transporter ABCA1 in cells. Falcarindiol induces apoptosis and autophagy. Falcarindiol has anti-inflammatory, antifungal, anticancer and antidiabetic properties . Falcarindiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12784A
CAS No.: 152-53-4
Purity:  99.93%
Synonyms: Chlorguanide triazine hydrochloride
Research Areas:  

Infection Cancer

Cycloguanil (Chlorguanide triazine) hydrochloride is a dihydrofolate reductase (DHFR) inhibitor with an IC50 of 10.8 μM against human DHFR. Cycloguanil hydrochloride blocks the folate metabolic pathway, thereby affecting nucleotide synthesis and interfering with DNA replication. Cycloguanil inhibits DHFR in Plasmodium and is thus used in malaria research. Cycloguanil hydrochloride also potently inhibits DHFR in human cancer cells and blocks the transcriptional activity of STAT3, thereby exhibiting anticancer activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103692
CAS No.: 851095-32-4
Purity:  99.21%
Target:  

STAT

Research Areas:  

Cancer

STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 inhibits STAT3 transcription with an IC50 of 74 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-129800
CAS No.: 258326-83-9
Purity:  99.33%
Target:  

ERK

Research Areas:  

Cancer

CGP78850 is a potent and selective competitor of Grb2 SH2-phosphopeptide interactions. CGP78850 can be used for the research of cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P990859

Research Areas:  

Cancer

Anti-CD44 Antibody (Hermes-1) is a kind of rat IgG2a κ chimeric antibody, targeting to human CD44. Anti-CD44 Antibody (Hermes-1) blocks the binding of hyaluronan to CD44. Anti-CD44 Antibody (Hermes-1) restores (Platelet-derived Growth Factor-BB)-induced β-receptor activation and motility in fibroblasts. Anti-CD44 Antibody (Hermes-1) causes partial loss of the anti-aging effect of hyaluronic .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135699
CAS No.: 1798328-24-1
Purity:  ≥95.0%
Target:  

Apoptosis Phosphatase Akt

Research Areas:  

Cancer

TD52, an Erlotinib (HY-50896) derivative, is an orally active, potent cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibitor. TD52 mediates the apoptotic effect in triple-negative breast cancer (TNBC) cells via regulating the CIP2A/PP2A/p-Akt signalling pathway. TD52 indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter. TD52 has less p-EGFR inhibition and has potent anti-cancer activity . TD52 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135699A
CAS No.: 2918778-70-6
Purity:  99.90%
Target:  

Akt Phosphatase Apoptosis

Research Areas:  

Cancer

TD52 dihydrochloride, an Erlotinib (HY-50896) derivative, is an orally active, potent cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibitor. TD52 dihydrochloride mediates the apoptotic effect in triple-negative breast cancer (TNBC) cells via regulating the CIP2A/PP2A/p-Akt signalling pathway. TD52 dihydrochloride indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter. TD52 dihydrochloride has less p-EGFR inhibition and has potent anti-cancer activity . TD52 (dihydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-115568
CAS No.: 2140289-17-2
Purity:  98.34%
Research Areas:  

Cancer

BETd-246 is a BRD2/3/4 PROTAC degrader targeting the BET family. BETd-246 induces ubiquitination and proteasomal degradation of BRD2, BRD3 and BRD4 by recruiting the CUL4-RBX1-DDB1-CRBN E3 ubiquitin ligase complex; it also inhibits TRAT1 expression and depletes BET proteins. BETd-246 suppresses cancer cell proliferation and invasion, disrupts the cell cycle and induces apoptosis. BETd-246 is applicable to research related to triple-negative breast cancer and T-cell acute lymphoblastic leukemia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-79256
CAS No.: 863971-12-4
Synonyms: Monomethyl auristatin F methyl ester
Target:  

ADC Payloads

Research Areas:  

Cancer

MMAF-Ome, an antitubulin agent, is also an ADC cytotoxin. MMAF-Ome inhibits several tumor cell lines with IC50s of 0.056 nM, 0.166 nM, 0.183 nM, and 0.449 nM for MDAMB435/5T4, MDAMB361DYT2, MDAMB468, and Raji (5T4 -) cell lines, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153992
CAS No.: 371919-80-1
Purity:  99.97%
Target:  

STAT

Research Areas:  

Inflammation/Immunology

STAT6-IN-3 is a phosphopeptide mimic targeting the SH2 domain of STAT6 and has a high affinity for STAT6 (IC50: 0.04 μM). STAT6-IN-3 can be used in the research of inflammation such as asthma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10395
CAS No.: 260415-63-2
Purity:  99.12%
Target:  

Bcr-Abl Src

Research Areas:  

Cancer

PD173955 is an orally active inhibitor of Src (IC50= 22 nM), Yes, Abl, ATP and MAP kinases. PD173955 can effectively prevent the mitotic process and has anticancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101982
CAS No.: 1281816-04-3
Purity:  99.61%
Synonyms: Lys-Nε-MCC-DM1
Research Areas:  

Cancer

Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is a agent-linker conjugates for ADC that can inhibit tubulin polymerization. Lys-SMCC-DM1 is the active metabolite of T-DM1. T-DM1 is a HER2-targeting ADC with a tubulin polymerization inhibitor DM1. Lys-SMCC-DM1 can be used in the research of breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148570
CAS No.: 2893778-31-7
Purity:  99.34%
Research Areas:  

Cancer

PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor. PHGDH-IN-3 inhibits PHGDH with an IC50 value of 2.8 μM. PHGDH-IN-3 can be used for the research of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-115997
CAS No.: 2669072-88-0
Purity:  99.54%
PROTAC HSP90 degrader BP3 is a potent and selective degradation of HSP90 in a CRBN-dependent fashion. PROTAC HSP90 degrader BP3 has a certain degradation effect on HSP90 protein in MCF-7 cells (DC50=0.99 μM). PROTAC HSP90 degrader BP3 inhibits the growth of breast cancer cell . PROTAC HSP90 degrader BP3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...